ELEZY vs. CRVS

Last updated Jun 5, 2026

ELEZY (Endesa SA ADR) and CRVS (Corvus Pharmaceuticals, Inc.) are both stocks. ELEZY operates in Utilities - Regulated Electric (Utilities), while CRVS operates in Biotechnology (Healthcare). Over the past 5 years, ELEZY returned 16.58%/yr vs 34.23%/yr for CRVS. At a 0.06 correlation, their price movements are largely independent.

Performance

ELEZY vs. CRVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Endesa SA ADR (ELEZY) and Corvus Pharmaceuticals, Inc. (CRVS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ELEZY achieves a 20.52% return, which is significantly lower than CRVS's 52.21% return.

ELEZY

• 1D: 2.11%
• 1M: -3.51%
• YTD: 20.52%
• 6M: 22.01%
• 1Y: 45.41%
• 3Y*: 31.97%
• 5Y*: 16.58%
• 10Y*: —

CRVS

• 1D: 1.03%
• 1M: -25.35%
• YTD: 52.21%
• 6M: 33.03%
• 1Y: 212.53%
• 3Y*: 52.88%
• 5Y*: 34.23%
• 10Y*: -1.93%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ELEZY vs. CRVS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ELEZY Endesa SA ADR	20.52%	75.81%	9.78%	19.46%	-14.63%	-12.87%	6.49%	22.67%	-0.34%	-4.48%
CRVS Corvus Pharmaceuticals, Inc.	52.21%	43.93%	203.98%	107.06%	-64.73%	-32.30%	-34.56%	48.23%	-64.58%	-38.22%

Correlation

The correlation between ELEZY and CRVS is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.09
Correlation (5Y) Calculated over the trailing 5-year period	0.09
Correlation (All Time) Calculated using the full available price history since Oct 4, 2017	0.06

Fundamentals

Market Cap ELEZY : $44.12B CRVS : $1.05B
EPS ELEZY : $1.11 CRVS : -$0.53
PB Ratio ELEZY : 5.15 CRVS : 4.38
Total Revenue (TTM) ELEZY : $21.28B CRVS : $0.00
Gross Profit (TTM) ELEZY : $1.31B CRVS : -$26.00K
EBITDA (TTM) ELEZY : $1.08B CRVS : -$47.43M

Return for Risk

ELEZY vs. CRVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELEZY

ELEZY Risk / Return Rank: 84
ELEZY Sharpe Ratio Rank: 84
ELEZY Sortino Ratio Rank: 80
ELEZY Omega Ratio Rank: 77
ELEZY Calmar Ratio Rank: 88
ELEZY Martin Ratio Rank: 89

CRVS

CRVS Risk / Return Rank: 87
CRVS Sharpe Ratio Rank: 76
CRVS Sortino Ratio Rank: 96
CRVS Omega Ratio Rank: 93
CRVS Calmar Ratio Rank: 87
CRVS Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELEZY vs. CRVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Endesa SA ADR (ELEZY) and Corvus Pharmaceuticals, Inc. (CRVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ELEZY	CRVS	Difference
Sharpe ratio: Return per unit of total volatility	1.70	1.18	+0.52
Sortino ratio: Return per unit of downside risk	2.34	4.47	-2.13
Omega ratio: Gain probability vs. loss probability	1.28	1.51	-0.22
Calmar ratio: Return relative to maximum drawdown	4.19	3.89	+0.30
Martin ratio: Return relative to average drawdown	11.53	8.69	+2.83
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ELEZY vs. CRVS - Sharpe Ratio Comparison

The current ELEZY Sharpe Ratio is 1.70, which is higher than the CRVS Sharpe Ratio of 1.18. The chart below compares the historical Sharpe Ratios of ELEZY and CRVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ELEZY	CRVS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.70	1.18	+0.52
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.53	0.26	+0.27
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.02	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.46	-0.02	+0.48

Drawdowns

ELEZY vs. CRVS - Drawdown Comparison

The maximum ELEZY drawdown since its inception was -50.29%, smaller than the maximum CRVS drawdown of -96.97%. Use the drawdown chart below to compare losses from any high point for ELEZY and CRVS.

Drawdown Indicators

	ELEZY	CRVS	Difference
Max Drawdown Largest peak-to-trough decline	-50.29%	-96.97%	+46.68%
Max Drawdown (1Y) Largest decline over 1 year	-10.89%	-54.94%	+44.05%
Max Drawdown (3Y) Largest decline over 3 years	-20.80%	-72.02%	+51.22%
Max Drawdown (5Y) Largest decline over 5 years	-43.16%	-92.40%	+49.24%
Max Drawdown (10Y) Largest decline over 10 years	—	-96.97%	—
Current Drawdown Current decline from peak	-6.50%	-54.08%	+47.58%
Average Drawdown Average peak-to-trough decline	-15.76%	-69.33%	+53.57%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.95%	24.56%	-20.61%

Volatility

ELEZY vs. CRVS - Volatility Comparison

The current volatility for Endesa SA ADR (ELEZY) is 8.51%, while Corvus Pharmaceuticals, Inc. (CRVS) has a volatility of 23.73%. This indicates that ELEZY experiences smaller price fluctuations and is considered to be less risky than CRVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ELEZY	CRVS	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.51%	23.73%	-15.22%
Volatility (6M) Calculated over the trailing 6-month period	21.32%	111.90%	-90.58%
Volatility (1Y) Calculated over the trailing 1-year period	26.77%	180.94%	-154.17%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	31.41%	131.04%	-99.63%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	36.15%	111.13%	-74.98%

Dividends

ELEZY vs. CRVS - Dividend Comparison

ELEZY's dividend yield for the trailing twelve months is around 3.64%, while CRVS has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019
CRVS Corvus Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ELEZY Endesa SA ADR	3.64%	4.12%	2.49%	11.14%	5.31%	9.35%	2.10%	2.80%

Financials

Frequently Asked Questions

Can I hold both ELEZY and CRVS in my portfolio?

ELEZY and CRVS have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ELEZY or CRVS?

CRVS has higher volatility (23.73%) compared to ELEZY (8.51%). In terms of maximum drawdown, ELEZY dropped -50.29% vs CRVS's -96.97%.

Which has better risk-adjusted returns?

ELEZY currently has the higher Sharpe Ratio (1.70 vs 1.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.